BioTime (BTX) CEO Dr. Michael West to Give Keynote Address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine Conference
8/19/2013 7:05:20 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, PhD will give the keynote address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine conference on Monday, August 19, 2013, at 12:15 p.m. EDT in Cleveland, Ohio. Dr. West will discuss the potential use of embryonic mesenchymal progenitor cells, generated using BioTime’s PureStem™ technology, in regenerative medicine and will contrast the properties of those cells with adult-derived mesenchymal stem cells.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by